Patents by Inventor Charles-Henry Robert Yves Fabritius

Charles-Henry Robert Yves Fabritius has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DISUBSTITUTED ALKYNE DERIVATIVES
    Publication number: 20230052586
    Abstract: The present invention relates to disubstituted alkyne derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.
    Type: Application
    Filed: December 20, 2019
    Publication date: February 16, 2023
    Inventors: Timo Heinrich, Carl Petersson, Mireille Krier, Andrzej Gondela, Michal Mikolaj Galezowski, Charles-Henry Robert Yves Fabritius, Mateusz Oktawian Nowak, Marcin Krol
  • SELECTIVE INHIBITORS OF NLRP3 INFLAMMASOME
    Publication number: 20210087147
    Abstract: The present disclosure relates to compounds of Formula (I): and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for inhibiting the maturation of cytokines of the IL-1 family by inhibiting inflammasomes and may be used in the treatment of disorders in which inflammasome activity is implicated, such as autoinflammatory and autoimmune diseases and cancers.
    Type: Application
    Filed: July 31, 2018
    Publication date: March 25, 2021
    Inventors: Mark G. BOCK, David HARRISON, Alan Paul WATT, Roderick Alan PORTER, Nicolas Felix Pierre BOUTARD, Charles-Henry Robert Yves FABRITIUS, Grzegorz Witold TOPOLNICKI, Oleksandr LEVENETS
  • SUBSTITUTED QUINOXALINE DERIVATIVES
    Publication number: 20180148429
    Abstract: The present invention relates to substituted quinoxaline derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.
    Type: Application
    Filed: May 12, 2016
    Publication date: May 31, 2018
    Inventors: Charles-Henry Robert Yves Fabritius, Mateusz Oktawian Nowak, Katarzyna Anna Wiklik, Aleksandra Barbara Sabiniarz, Marcin Dominik Bien, Anna Malgorzata Buda, Pawel Szczepan Guzik, Krzysztof Roman Jakubiec, Monika Maciuszek, Katarzyna Kwiecinska, Mateusz Michal Tomczyk, Michal Mikolaj Galezowski, Andrzej Gondela, Lukasz Piotr Dudek
  • Substituted Quinoxaline Derivatives
    Publication number: 20180118718
    Abstract: The present invention relates to substituted quinoxaline derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.
    Type: Application
    Filed: May 12, 2016
    Publication date: May 3, 2018
    Applicant: Selvita S.A.
    Inventors: Charles-Henry Robert Yves Fabritius, Mateusz Oktawian Nowak, Katarzyna Anna Wiklik, Aleksandra Barbara Sabiniarz, Marcin Dominik Bien, Anna Malgorzata Buda, Pawel Szczepan Guzik, Arkadiusz Kacper Bialas, Henryk Edward Pawlik, Nicolas Felix Pierre Boutard